Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8068

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A chart showing the pharmacokinetic fold change and 90% confidence interval for Venlafaxine Hydrochloride when co-administered with various interacting drugs. The x-axis represents fold change relative to a reference value, with recommendations for dose adjustment or cautionary use based on the interaction. Drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium are listed with their effects on Venlafaxine's Cmax, AUC, and other parameters.*

FDA Label Image

Figure2 (Figure2)

A pharmacokinetic-fold change plot showing the interaction effects of various drugs on the analyte parameters Cmax and AUC. The chart lists interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium with associated fold changes and 90% confidence intervals, along with recommendations for dose adjustments or clinical significance comments.*

FDA Label Image

Figure3 (Figure3)

A scatter plot chart illustrating pharmacokinetic changes and dosing recommendations for venlafaxine and its metabolite ODV in special populations. The chart displays fold change and 90% confidence intervals on the x-axis, comparing Cmax and AUC values across hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender groups, with corresponding dosing adjustment recommendations on the right side.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxine HCl Extended-release Capsules 75mg (Venlafaxine Hydrochloride 75mg 30 Capsules)

Label for Venlafaxine Hydrochloride Extended-Release Capsules 75 mg, generic for Effexor ER, manufactured by Preferred Pharmaceuticals, Inc. The label features directions in English and Spanish and includes storage instructions and warnings. The capsules are described as pink and white.*

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure of Venlafaxine Hydrochloride showing its molecular framework including the chiral center, aromatic ring with methoxy group, cyclohexane ring, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.